BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17060558)

  • 1. Aging of the brain, entropy, and Alzheimer disease.
    Drachman DA
    Neurology; 2006 Oct; 67(8):1340-52. PubMed ID: 17060558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.
    Burns JM; Church JA; Johnson DK; Xiong C; Marcus D; Fotenos AF; Snyder AZ; Morris JC; Buckner RL
    Arch Neurol; 2005 Dec; 62(12):1870-6. PubMed ID: 16344345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.
    Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S
    J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
    Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
    Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.
    Hoyer S
    Eur J Pharmacol; 2004 Apr; 490(1-3):115-25. PubMed ID: 15094078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm?
    Imhof A; Kövari E; von Gunten A; Gold G; Rivara CB; Herrmann FR; Hof PR; Bouras C; Giannakopoulos P
    J Neurol Sci; 2007 Jun; 257(1-2):72-9. PubMed ID: 17303173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plurality of patterns of cognitive impairment in normal aging and in dementia].
    Joanette Y; Belleville S; Gely-Nargeot M; Ska B; Valdois S
    Rev Neurol (Paris); 2000 Sep; 156(8-9):759-66. PubMed ID: 10992120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and the brain: a new frontier.
    Drachman DA
    Ann Neurol; 1997 Dec; 42(6):819-28. PubMed ID: 9403473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease pathogenesis: role of aging.
    Harman D
    Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.
    Hellström-Lindahl E; Ravid R; Nordberg A
    Neurobiol Aging; 2008 Feb; 29(2):210-21. PubMed ID: 17098332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of brain aging and neurodegenerative disorders.
    Wisniewski T; Frangione B
    Acta Neurobiol Exp (Wars); 1996; 56(1):267-79. PubMed ID: 8787186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal networks in Alzheimer's disease.
    He Y; Chen Z; Gong G; Evans A
    Neuroscientist; 2009 Aug; 15(4):333-50. PubMed ID: 19458383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
    Kidd PM
    Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.